Compare CMMB & GXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CMMB | GXAI |
|---|---|---|
| Founded | 2004 | 2021 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.2M | 11.7M |
| IPO Year | 2023 | 2022 |
| Metric | CMMB | GXAI |
|---|---|---|
| Price | $1.58 | $1.28 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $25.00 | N/A |
| AVG Volume (30 Days) | 47.1K | ★ 8.3M |
| Earning Date | 05-14-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 101.67 | 71.35 |
| EPS | ★ 0.04 | N/A |
| Revenue | N/A | ★ $1,933,030.00 |
| Revenue This Year | N/A | $79.41 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $39.00 | ★ N/A |
| Revenue Growth | N/A | ★ 47901.74 |
| 52 Week Low | $0.87 | $1.00 |
| 52 Week High | $3.86 | $2.96 |
| Indicator | CMMB | GXAI |
|---|---|---|
| Relative Strength Index (RSI) | 42.83 | 49.11 |
| Support Level | $1.48 | $1.22 |
| Resistance Level | $1.64 | $1.31 |
| Average True Range (ATR) | 0.18 | 0.11 |
| MACD | -0.03 | -0.02 |
| Stochastic Oscillator | 14.00 | 31.37 |
Chemomab Therapeutics Ltd is a clinical-stage biotechnology company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases.
Gaxos.AI Inc is revolutionizing the way humans interact with artificial intelligence. The company offers applications related to mental and physical well-being, coaching, and gaming. The group is committed to tackling contemporary challenges such as how to live healthier and how to live longer. In addition to offering human-centered solutions, the company uses empathetic and AI technologies.